Stempoint Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.9M | Buy |
707,915
+40,837
| +6% | +$571K | 3.18% | 11 |
|
|
2025
Q1 | $9.07M | Buy |
667,078
+82,750
| +14% | +$1.12M | 2.89% | 12 |
|
|
2024
Q4 | $11.9M | Buy |
584,328
+302,278
| +107% | +$6.16M | 2.97% | 9 |
|
|
2024
Q3 | $8.22M | Buy |
282,050
+31,040
| +12% | +$904K | 2.46% | 14 |
|
|
2024
Q2 | $5.83M | Buy |
+251,010
| New | +$5.83M | 1.71% | 19 |
|